Table 2 Mortality among heFH and control first-degree family members
From: Current causes of death in familial hypercholesterolemia
heFH family members | NonheFH family members | Control family members | P | |
|---|---|---|---|---|
N | 211 | 219 | 372 | |
Total death, N (%) | 62 (29.4) | 53 (24.2) | 100 (26.9) | 0.479 |
Age of death (years) | 69.3 (13.9) | 73.5 (16.2) | 73.2 (13.8) | 0.179 |
Age of Cardiovascular disease death (years) | 65.9 (13) | 77.5 (12) | 77.5 (13.2) | 0.001 |
Age of Non-cardiovascular death (years) | 73.9 (13.8) | 71.4 (17.6) | 71.72 (14.6) | 0.792 |
Cardiovascular disease death, N (%) | 37 (59.7) | 20 (37.7) | 37 (37.4) | 0.012 |
Non-cardiovascular death, N (%) | 25 (40.3) | 33 (62.3) | 62 (62.6) | |
Cancer death, N (%) | 12 (48.0) | 14 (42.0) | 31 (50.0) | 0.779 |
Other death, N (%) | 13 (52.0) | 19 (57.5) | 31 (50.0) | |
Statin treatment, N (%) | 107 (50.7) | 29 (13.2) | 53 (14,2) | 0.001 |